Vimarsana
Biggest News Aggregation in the World

Page 2 - Alpha Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpha Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpha Therapy Today - Breaking & Trending Today

CNL announces joint venture in production of cancer-fighting isotope | Kingston/Frontenac This Week - Vimarsana News

CNL announces joint venture in production of cancer-fighting isotope | Kingston/Frontenac This Week

CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.

ITM and CNL Announce the Launch of Actineer, a New Joint - Vimarsana News

ITM and CNL Announce the Launch of Actineer, a New Joint

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale...

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of ... - Vimarsana News

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of ...

GARCHING, Germany, MUNICH Germany and CHALK RIVER, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL),

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225 - Vimarsana News

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope 

Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides Corporate Update Highlighting Key Upcoming Milestones - Vimarsana News

Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides Corporate Update Highlighting Key Upcoming Milestones

On track to report topline data from the Pivotal Phase 3 SIERRA trial for Iomab-B in Q4 2022 Overall survival data from the Actimab-A CLAG-M combination trial...